Faculty:  Richard ZuWallack, MD
       (view biosketch)
Release Date: December 4, 2009
Learning Objectives:
  • Discuss the limitations faced in the idenification and evaluation of COPD patients
  • Review new diagnostic guidelines for the assessment of patients with COPD
  • Identify current treatment options for patients diagnosed with COPD
  • Integrate new diagnostic guidelines into a management and treatment plan
Accreditation Statement:
The American Academy of Physician Education is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide
continuing medical education for physicians. The American Academy of Physician Education takes responsibility for the content, quality and scientific
integrity of this CME activity.

Credit Designation Statement:
The American Academy of Physician Education designates this educational activity for a maximum of 2.0 hours AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA
Certification in Continuing Medical Education.
Commercial Support: This activity is supported by an educational grant from Astra Zeneca.
Target Audience:
This activity is designed for primary care physicians, intensivists, pulmonologists, allergists, physician assistants, nurse practitioners, and other
healthcare professionals interested in recognition of early symptoms, diagnosis, treatment, and long-term management of COPD.
Activity Description:
COPD is an irreversible condition primarily associated with smoking, but also has a genetic component as well as environmental and occupational
risk factors. Diagnosising COPD is a challenge due to the lung capacity. Healthy individuals have reserve lung capacity and it is not until this lung
capacity is greatly diminished that the symptoms of COPD become evident. However, when spirometry and clinical examination are used in concert,
the accuracy of COPD diagnosis is increased. To accomplish this, clinicians need to be able to differentiate COPD from other pulmonary disorders
including asthma and congestive heart failure. Significant comorbidities must be taken into account in a comprehensive diagnostic assessment of
severity and in determining appropriate treatment. Clinicians need to be aware of the recommended step-wise approach to developing a treatment
plan for patients with COPD. Beginning in the mild stages, clinicians need to be treating the current symptoms as well as preventing as many
exacerbations as possible. As the patient progresses to moderate, severe, and very-severe COPD, the treatment plan needs to be constantly
evaluated and adapted accordingly.
Disclosures:
As a CME provider accredited by Institute for Medical Quality/California Medical Association (IMQ/CMA), AA-PE requires all individuals (and their
significant others) in a position to influence and/or control the content of AA-PE directly and co-sponsored CME activities to disclose to AA-PE and
subsequently to learners that the individual either has no relevant financial relationships or has any relevant financial relationships with a
commercial interest. Individuals are required to disclose the following information per ACCME Standard 6.1 (see Standards of Commercial Support,
ACCME www.accme-assn.org): name of the individual, name of the commercial interest(s), and nature of the financial relationship the individual has
with each commercial interest. If a conflict of interest is found, in accordance with standards for Commercial Support issued by the Accreditation
Council for Continuing Medical Education (ACCME) AA-PE requires resolution of all faculty conflicts of interest to ensure CME activities are free of
commercial bias.

Richard ZuWallack, MD discloses that he is a member of the advisory boards for scientific information for Genentech, Biogen, IDEC, Celgene, GSK,
Millennium, Wyeth, Immunomedics, Novartis, Biotest, Johnson and Johnson, Enzon, Gloucester.

Off-Label Disclosure:
The faculty has disclosed that this activity includes discussion of either non-FDA-approved or investigational agents.
Instructions for Participation and Credit:
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of
continuing education credit for this activity, please consult your professional licensing board.

This activity is designed for completion within the designated time listed on the title page; physicians should claim only those credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted
on the title page.

Follow these steps to earn CME/CE credit*:
Read the target audience, learning objectives, and author disclosures.
Study the educational audio and slide presentation online.  You may also print out a copy of the syllabi.

Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test.
AA-PE encourages you to complete the Activity Evaluation to provide feedback for future programming.
Receiving Credit:
The estimated time for the completion of this activity—which consists of two (2) presentations—is 2.0 hours. To be eligible for CME credit,
participants must complete both a pre and post-test. Upon submission of the post-test with a score of 80% or better, and completion of the
evaluation, you will immediately receive your electronic certificate, which you may print and/or save as documentation of completion. You can only
claim and receive credit for this activity once. If you plan to complete a portion of the activity, and return at a later date to complete the remainder,
please wait to claim your credit until you have completed all of the activity.

Our Commitment to Privacy:
AAPE and Stream 57 respect the privacy of every individual who participates in this activity. Because your privacy is important to us, we provide you
with notice about the collection and use of your information. By continuing with this activity, you accept the practices described in this privacy notice.

We collect two types of information:
Standard Web server traffic pattern information. General traffic, site usage, and length of stay information is collected and stored in log files. This type
of information may be shared externally only on an aggregated basis. We do not use cookies on our Web site.

Personal information. We do not collect personally identifiable information from you unless you provide it to us voluntarily and knowingly. The
information you provide in order to provide you with credit for completing the online activity includes the following information: first and last name,
street address, city, state, zip code, telephone number, area of practice, email address and other pertinent information. This information will be
collected when you claim credit registration form.

We limit the use of information provided to us on the CME site to the following:

We will only use aggregate information derived, in part, from your use of our site to improve our site and our service to you.

We will maintain records of the data you provide during registration.

Contact Us:
For CME Information or credit details contact AA-PE at cme@mdedu.org.

Copyright:
©2009 American Academy of Physician Education and Stream 57. All rights reserved. None of the contents of this activity may be reproduced in any
form without prior written permission from AA-PE or Stream 57.